Newsroom

ICYMI: CSRxP Corrects The Record On Price Transparency

The Trump Administration took another step earlier this month to help lower drug prices by proposing a new regulation that would require drug makers to include […]

Read more

CSRxP Statement On The Trump Administration’s Proposal To Change Medicare Drug Prices

For Immediate Release: Contact: Lauren Blair (201) 213-5004 lblair@fp1strategies.com The Campaign for Sustainable Rx Pricing (CSRxP) issued the following statement in response to the U.S. Department […]

Read more

SECOND OPINION: Don’t Be Fooled.  Drug Companies Are Responsible For High Drug Prices

Repeating the same false claim over and over again doesn’t make it true.  That’s the message Forbes Opinion Editor and health care expert Avik Roy is […]

Read more

CSRxP Statement On HHS DTC Advertising Announcement

CSRxP issued the following statement in response to the U.S. Department of Health and Human Services’ (HHS) announcement on direct-to-consumer (DTC) television advertisements:   “Today, the […]

Read more